Restricted accessLetterFirst published online 2024-8
Letter: The Value of Systemic-Immune Inflammatory Response Index in Predicting Contrast-Induced Nephropathy in Patients With ST-Elevation Myocardial Infarction
ŞaylıkFÇınarTSarıkayaRTanboğaİH. Development and validation of nomogram based on the systemic-immune inflammation response index for predicting contrast-induced nephropathy in ST-elevation myocardial infarction patients. Angiology. 2024;75:673-681.
2.
MangaleshSDudaniSMaheshNK. Development of a novel inflammatory index to predict coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2023; 33197231151564. doi:10.1177/00033197231151564
3.
ÖztürkRİnanDGüngörB. Systemic immune-inflammation index is a predictor of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2022;73:125-131.
4.
BağcıAAksoyFBaşHA. Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2022;73:218-224.
5.
KarauzumIKarauzumKHanciKGokcekDKalasBUralE. The utility of systemic immune-inflammation index for predicting contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiorenal Med. 2022;12:71-80.
6.
ZhangFLuZWangF. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020;259:118379.
